Alpine Partners VI »

Intra Cellular Therapies shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $2.4M 35k 68.49

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Microstrategy Cl A New (MSTR)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Microsoft Corporation (MSFT)
Live Nation Entertainment In Note 2.000% 2/1
Rivian Automotive Note 4.625% 3/1
Vishay Intertechnology Note 2.250% 6/1
Veeco Instrs Inc Del Note 2.875% 6/0
Alphabet Cap Stk Cl A (GOOGL)
Snap Note 0.125% 3/0
Burlington Stores Note 2.250% 4/1
Ncl Corp Note 5.375% 8/0

View all positions for Alpine Partners VI

Top funds holding Intra Cellular Therapies

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
Daniel D. Thurber
Invesco
Bellevue Group
State Street Corporation
Franklin Resources
ClearBridge Advisors
Geode Capital Management
Perceptive Advisors
Pictet Asset Management Holding SA
Suvretta Capital Management
Deep Track Capital

View all funds holding Intra Cellular Therapies